Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Modafinil on Olanzapine Weight Gain

This study has been completed.
Sponsor:
Collaborators:
Eli Lilly and Company
University of North Dakota
Information provided by:
Neuropsychiatric Research Institute, Fargo, North Dakota
ClinicalTrials.gov Identifier:
NCT00636896
First received: March 10, 2008
Last updated: NA
Last verified: March 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)